CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition

被引:0
|
作者
Bottai, G.
Loi, S.
Sotiriou, C.
Roncalli, M.
Pusztai, L.
Reis-Filho, J. S.
Santarpia, L.
机构
[1] Humanitas Clin & Res Ctr, Milan, Italy
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Inst Jules Bordet, Brussels, Belgium
[4] Humanitas Univ, Milan, Italy
[5] Yale Canc Ctr, New Haven, CT USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1158/1538-7445.SABCS16-P2-04-16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-04-16
引用
收藏
页数:2
相关论文
共 50 条
  • [41] TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer
    Byrd, Tiara T.
    Fousek, Kristen
    Pignata, Antonella
    Szot, Christopher
    Samaha, Heba
    Seaman, Steven
    Dobrolecki, Lacey
    Salsman, Vita S.
    Oo, Htoo Zarni
    Bielamowicz, Kevin
    Landi, Daniel
    Rainusso, Nino
    Hicks, John
    Powell, Suzanne
    Baker, Matthew L.
    Wels, Winfried S.
    Koch, Joachim
    Sorensen, Poul H.
    Deneen, Benjamin
    Ellis, Matthew J.
    Lewis, Michael T.
    Hegde, Meenakshi
    Fletcher, Bradley S.
    St Croix, Brad
    Ahmed, Nabil
    CANCER RESEARCH, 2018, 78 (02) : 489 - 500
  • [42] Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
    Bajrami, Ilirjana
    Kigozi, Asha
    Van Weverwijk, Antoinette
    Brough, Rachel
    Frankum, Jessica
    Lord, Christopher J.
    Ashworth, Alan
    EMBO MOLECULAR MEDICINE, 2012, 4 (10) : 1087 - 1096
  • [43] The effectiveness of autophagy inhibition in sensitizing triple-negative breast cancer cells to chemotherapy
    Bortnik, Svetlana
    Chittaranjan, Suganthi
    Xu, Jing
    Dragowska, Wieslawa H.
    An, Jianghong
    Kyle, Adrienne
    Go, Nancy E.
    Vezenkov, Lubomir
    Choutka, Courtney
    Leung, Amy
    Kovacic, Suzana
    Bosc, Damien
    Gelmon, Karen
    Bally, Marcel
    Jones, Steven
    Young, Robert
    Gorski, Sharon
    CANCER RESEARCH, 2015, 75
  • [44] Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer
    Suzuki, Kazushi
    Ohe, Rintaro
    Kabasawa, Takanobu
    Kitaoka, Takumi
    Kawai, Masaaki
    Motoi, Fuyuhiko
    Futakuchi, Mitsuru
    BREAST CANCER, 2023, 30 (06) : 1094 - 1104
  • [45] PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells
    Byerly, Jessica
    Halstead-Nussloch, Gwyneth
    Ito, Koichi
    Katsyv, Igor
    Irie, Hanna Y.
    BREAST CANCER RESEARCH, 2016, 18
  • [46] Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer
    Tang, Yuxia
    Wang, Siqi
    Li, Yang
    Yuan, Chen
    Zhang, Jie
    Xu, Ziqing
    Hu, Yongzhi
    Shi, Haibin
    Wang, Shouju
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [47] BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer
    Jing, Xin
    Shao, Shan
    Zhang, Yujiao
    Luo, Anqi
    Zhao, Lin
    Zhang, Lifen
    Gu, Shanzhi
    Zhao, Xinhan
    EXPERIMENTAL CELL RESEARCH, 2020, 392 (02)
  • [48] Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer
    Yuxia Tang
    Siqi Wang
    Yang Li
    Chen Yuan
    Jie Zhang
    Ziqing Xu
    Yongzhi Hu
    Haibin Shi
    Shouju Wang
    Journal of Nanobiotechnology, 20
  • [49] CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
    Cheung, Anthony
    Chenoweth, Alicia M.
    Quist, Jelmar
    Sow, Heng Sheng
    Malaktou, Christina
    Ferro, Riccardo
    Hoffmann, Ricarda M.
    Osborn, Gabriel
    Sachouli, Eirini
    French, Elise
    Marlow, Rebecca
    Lacy, Katie E.
    Papa, Sophie
    Grigoriadis, Anita
    Karagiannis, Sophia N.
    CANCERS, 2022, 14 (14)
  • [50] Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer
    Kazushi Suzuki
    Rintaro Ohe
    Takanobu Kabasawa
    Takumi Kitaoka
    Masaaki Kawai
    Fuyuhiko Motoi
    Mitsuru Futakuchi
    Breast Cancer, 2023, 30 : 1094 - 1104